SHINICHIRO OHSHIMO

Last Updated :2021/10/05

Affiliations, Positions
Graduate School of Biomedical and Health Sciences(Medicine), Associate Professor
Web Site
E-mail
ohshimoshiroshima-u.ac.jp
Other Contact Details
1-2-3,Kasumi,Minami-ku,Hiroshima, Japan
TEL : (+81)81-82-257-5 FAX : (+81)
Self-introduction
My research field is the emergency and critical care medicine, predominantly acute respiratory failure and sepsis. My specialty is the acute exacerbation of idiopathic pulmonary fibrosis and the extracorporeal membrane oxygenation (ECMO).

Basic Information

Major Professional Backgrounds

  • 2008/04/01, 2009/03/31, Department of Respiratory Medicine, Hiroshima University Hospital, Research associate
  • 2009/04/01, 2014/03/31, Department of Intensive Care Medicine, Hiroshima University Hospital, Research Associate
  • 2014/04/01, 2017/03/31, Advanced Emergency and Critical Care Center, Hiroshima University Hospital, Associate Professor or Lecturer
  • 2017/04/01, 2019/03/31, Department of Emergency and Critical Care Medicine, Graduate School of Biomedical & Health Sciences, Hiroshima University, Associate Professor

Academic Degrees

  • MD, PhD, Hiroshima University

Educational Activity

  • [Bachelor Degree Program] School of Medicine : Program of Medicine : Medicine
  • [Master's Program] Graduate School of Biomedical and Health Sciences : Division of Integrated Health Sciences
  • [Doctoral Program] Graduate School of Biomedical and Health Sciences : Division of Biomedical Sciences : Program of Medicine

Research Fields

  • Medicine,dentistry, and pharmacy;Clinical surgery;Emergency medicine

Research Keywords

  • acute respiratory failure
  • interstitial lung diseases; idiopathic pulmonary fibrosis
  • extracorporeal membrane oxygenation; ECMO
  • sepsis
  • Mechanical ventilation
  • Respiratory physiology

Affiliated Academic Societies

  • Japanese Association for Acute Medicine
  • Japanese Society of Intensive Care Medicine
  • Japanese Society of Internal Medicine
  • Japanese Respiratory Society
  • Japan Society of Respiratory Care Medicine
  • Japan Society for Respiratory Endoscopy
  • American Thoracic Society
  • European Respiratory Society
  • World Association for Sarcoidosis and Other Granulomatous Disorders
  • Japan Society for Blood Purification in Critical Care
  • Japanese Society of Reanimatology

Educational Activity

Course in Charge

  1. 2021, Undergraduate Education, Year, Systemic Disease Control
  2. 2021, Undergraduate Education, Intensive, Practice for medical research
  3. 2021, Undergraduate Education, Intensive, Practice of Medicine I
  4. 2021, Undergraduate Education, Intensive, Practice of Medicine II

Award of Education

  1. 2021/06/10
  2. 2021/03/19
  3. 2021/02/11
  4. 2019/02/08
  5. 2020/03/06, Reviewer of the year 2019
  6. 2020/11/12
  7. 2020/06/25
  8. 2017/09/22, Hiroshima University
  9. 2019/02/08, Hiroshima University
  10. 2019/06/27, Hiroshima University

Research Activities

Academic Papers

  1. Differences in serum SP-D levels between German and Japanese subjects are associated with SFTPD gene polymorphisms, BMC MEDICAL GENETICS, 15, 20140108
  2. Different MUC1 gene polymorphisms in German and Japanese ethnicities affect serum KL-6 levels, RESPIRATORY MEDICINE, 106(12), 1756-1764, 201212
  3. ★, KL-6, a Human MUC1 Mucin, as a prognostic marker for diffuse alveolar hemorrhage syndrome, ORPHANET JOURNAL OF RARE DISEASES, 7, 20121217
  4. Usefulness monitoring of circulating KL-6 in patients with advanced non-small cell lung cancers treated with gefitinib therapy., International journal of cancer, 122(11), 2612-2620, 20080601
  5. ★, Significance of bronchoalveolar lavage for the diagnosis of idiopathic pulmonary fibrosis., Am J Respir Crit Care Med, 179(11), 1043-1047, 20090601
  6. Erlotinib efficacy and cerebrospinal fluid concentration in patients with lung adenocarcinoma developing leptomeningeal metastases during gefitinib therapy., Cancer Chemother Pharmacol, 67(6), 1465-9, 20110101
  7. Regresson of a primary pulmonary adenocarcinoma after zoledronic acid monotherapy., Hiroshima J. Med. Sci, 60(1), 7-9, 20110301
  8. ★, KL-6, a human MUC1 mucin, promotes proliferation and survival of lung fibroblasts, 20051201
  9. ★, Bronchoalveolar lavage in other interstitial lung diseases, 20071001
  10. Diagnosis of sarcoidosis, 20080901
  11. Esophageal sarcoidosis presenting as pseudodiverticulum, 20080901
  12. Significance of bronchoalveolar lavage for the diagnosis of idiopathic pulmonary fibrosis, 20090601
  13. Angiogenic and angiostatic chemokines in idiopathic pulmonary fibrosis and granulomatous lung disease, 20091001
  14. Serum KL-6 as a novel disease marker in adolescent and adult cystic fibrosis, 20090701
  15. Diagnostic modalities in sarcoidosis: BAL, EBUS, and PET, 20100801
  16. Surfactant protein D and KL-6 serum levels in systemic sclerosis: correlation with lung and systemic involvement, 20110701
  17. Comparison of serum KL-6 versus bronchoalveolar lavage neutrophilia for the diagnosis of bronchiolitis obliterans in lung transplantation, 20110801
  18. Pulmonary alveolar proteinosis: New insights from a single-center cohort of 70 patients, 20110901
  19. Phase I study docetaxel plus S-1 combination chemotherapy for recurrent non-small cell lung cancer., Oncology Letters, 2, 167-170, 20110101
  20. ★, Comparison of serum KL-6 versus bronchoalveolar lavage neutrophilia for the diagnosis of bronchiolitis obliterans in lung transplantation., J Heart Lung Transplant, 30(12), 1374-1380, 20110801
  21. KL-6, a human MUC1 mucin, promotes proliferation and survival of lung fibroblasts, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 338(4), 1845-1852, 20051230
  22. Circulating KL-6/MUC1 mucin carrying sialyl Lewis(a) oligosaccharide is an independent prognostic factor in patients with lung adenocarcinoma, INTERNATIONAL JOURNAL OF CANCER, 120(12), 2643-2649, 20070615
  23. Usefulness of monitoring the circulating Krebs von den Lungen-6 levels to predict the clinical outcome of patients with advanced nonsmall cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors, INTERNATIONAL JOURNAL OF CANCER, 122(11), 2612-2620, 20080601
  24. Phase I study of docetaxel plus S-1 combination chemotherapy for recurrent non-small cell lung cancer, ONCOLOGY LETTERS, 2(1), 167-170, 2011
  25. Erlotinib efficacy and cerebrospinal fluid concentration in patients with lung adenocarcinoma developing leptomeningeal metastases during gefitinib therapy, CANCER CHEMOTHERAPY AND PHARMACOLOGY, 67(6), 1465-1469, 201106
  26. SURFACTANT PROTEIN D AND KL-6 SERUM LEVELS IN SYSTEMIC SCLEROSIS: CORRELATION WITH LUNG AND SYSTEMIC INVOLVEMENT, SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 28(1), 27-33, 201107
  27. Pulmonary alveolar proteinosis: New insights from a single-center cohort of 70 patients, RESPIRATORY MEDICINE, 105(12), 1908-1916, 201112
  28. Hypersensitivity Pneumonitis, IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 32(4), 537-+, 201211
  29. Serum KL-6 is a predictor of outcome in pulmonary alveolar proteinosis, ORPHANET JOURNAL OF RARE DISEASES, 8, 20130404
  30. ★, Baseline KL-6 predicts increased risk for acute exacerbation of idiopathic pulmonary fibrosis, RESPIRATORY MEDICINE, 108(7), 1031-1039, 201407
  31. ★, A pilot study: a combined therapy using polymyxin-B hemoperfusion and extracorporeal membrane oxygenation for acute exacerbation of interstitial pneumonia., Sarcoidosis Vasc Diffuse Lung Dis, 31(4), 343-349, 2015
  32. MUC5B promoter polymorphism in Japanese patients with idiopathic pulmonary fibrosis, RESPIROLOGY, 20(3), 439-444, 2015
  33. Exploring causative pathology is essential for validating harmful effects of late intubation, Crit Care Med, (in press), 2016
  34. MUC1 gene polymorphisms are associated with serum KL-6 levels and pulmonary dysfunction in pulmonary alveolar proteinosis., Orphanet J Rare Dis, 11, 48-48, 2016
  35. Long-term pulmonary complications of chemical weapons exposure in former poison gas factory workers., Inhal Toxicol, (in press), 2016
  36. Comparative Study of Circulating MMP-7, CCL18, KL-6, SP-A, and SP-D as Disease Markers of Idiopathic Pulmonary Fibrosis., Dis Markers, (in press), 2016
  37. ★, Innovation in Respiratory Sound Analysis, Ann Intern Med, 164(9), 638-639, 201603
  38. Exploring potential co-factors affecting coagulation and inflammation activity during extracorporeal membrane oxygenation, Crit Care Med, (in press), 2016
  39. Are probiotics actually useful in decreasing VAP rate?, Intensive Care Med, (in press), 2016
  40. Pediatric cardiorespiratory failure successfully managed with venoarterial-venous extracorporeal membrane oxygenation, BMC Pulm Med, 16, 20160812
  41. Influencing factor of biomarkers of endothelial and alveolar epithelial dysfunction, Intensive Care Med, (in press), 2016
  42. Is transpulmonary pressure-guided PEEP titration really optimal?, Intensive Care Med, (in press), 2016
  43. Potential covariates that affect post-extubation breathing effort in children., Intensive Care Med, (in press), 2016
  44. Serum YKL-40 as predictor of outcome in hypersensitivity pneumonitis, Eur Respir J, (in press), 2016
  45. Pediatric cardiorespiratory failure successfully managed with venoarterial-venous extracorporeal membrane oxygenation: a case report, BMC PULMONARY MEDICINE, 16, 20160812
  46. FAM13A polymorphism as a prognostic factor in patients with idiopathic pulmonary fibrosis, RESPIRATORY MEDICINE, 123, 105-109, 201702
  47. ★, Serum YKL-40 as predictor of outcome in hypersensitivity pneumonitis, EUROPEAN RESPIRATORY JOURNAL, 49(2), 2018
  48. AGER gene polymorphisms and soluble receptor for advanced glycation end product in patients with idiopathic pulmonary fibrosis, RESPIROLOGY, 22(5), 965-971, 201707
  49. The clinical practice guideline for the management of ARDS in Japan, JOURNAL OF INTENSIVE CARE, 5, 20170725
  50. Gene expression profiling of idiopathic interstitial pneumonias (IIPs): identification of potential diagnostic markers and therapeutic targets, BMC MEDICAL GENETICS, 18, 20170818
  51. CLINICAL AND MOLECULAR FEATURES OF RAPIDLY PROGRESSIVE CHRONIC HYPERSENSITIVITY PNEUMONITIS, SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 34(1), 48-57, 2017
  52. Differential diagnosis of granulomatous lung disease: clues and pitfalls, EUROPEAN RESPIRATORY REVIEW, 26(145), 201709
  53. AGER rs2070600 polymorphism elevates neutrophil-lymphocyte ratio and mortality in metastatic lung adenocarcinoma, ONCOTARGET, 8(55), 94382-94392, 20171107
  54. Serum YKL-40 is a reliable biomarker for pulmonary alveolar proteinosis, RESPIROLOGY, 22(7), 1371-1378, 201710
  55. The extent of ground-glass attenuation is a risk factor of chemotherapy-related exacerbation of interstitial lung disease in patients with non-small cell lung cancer, CANCER CHEMOTHERAPY AND PHARMACOLOGY, 81(1), 131-139, 201801
  56. Comparison of extracorporeal membrane oxygenation outcome for influenza-associated acute respiratory failure in Japan between 2009 and 2016, JOURNAL OF INTENSIVE CARE, 6, 20180711
  57. Potential Confounders of the Accuracy and Reliability of Delirium Assessment Tools, Crit Care Med, 45(1), e114, 201701
  58. Outcome Prediction for Acute Respiratory Distress Syndrome: Are the Current Three Variables Really Optimal?, Crit Care Med, 45(2), e237-e238, 201702
  59. Is Higher Cerebral Oxygen Saturation Really Predictive of Favorable Neurologic Outcome After In-Hospital Cardiac Arrest?, Crit Care Med, 45(4), e468-e469, 201704
  60. MUC1 in lung adenocarcinoma: cross-sectional genetic and serological study., BMC Cancer, 17(1), 263-263, 201704
  61. Next Step to Understanding Subphenotypes of Acute Respiratory Distress Syndrome, Am J Respir Crit Care Med, 196(6), 795-796, 201709
  62. Optimal Cutoff Value for Lung Injury Prediction Score and Potential Confounders for Identifying the Risk of Developing Acute Respiratory Distress Syndrome, Crit Care Med, 45(6), e624-e625, 201706
  63. Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case-cohort study, Eur Respir J, 50(2), pii: 1700936-pii: 1700936, 201708
  64. Combined rupture of left ventricular free wall and pericardium, Intensive Care Med, 43(12), 1858-1859, 201712
  65. Potential factors affecting lung inhomogeneity in acute respiratory distress syndrome., Intensive Care Med, 44(1), 125-126, 201801
  66. Does enhanced antibiotic de-escalation really have no benefit in the ICU?, Crit Care, 21(1), 270-270, 201711
  67. Confounders Affecting the Prognosis in Patients With Acute Decompensated Heart Failure Who Underwent Extracorporeal Membrane Oxygenation, Crit Care Med, 45(12), e1309-e1309, 201712
  68. Potential Confounders of Procalcitonin-Guided Antibiotic Therapy for Sepsis, Crit Care Med, 45(12), e1310-e1311, 201712
  69. Is Oxygenation Really an Intrinsic Predictive Factor of Mortality in Patients Undergoing Extracorporeal Life Support?, Crit Care Med, 46(2), e181-e182, 201802
  70. Confounders for interpreting the benefit of a biomarker-based strategy in early discontinuation of empirical antifungal therapy, Intensive Care Med, 44(3), 399-400, 201803
  71. Accurate Quantification of Pleural Effusion and Cofactors Affecting Weaning Failure, Anesthesiology, 128(3), 678-679, 201803
  72. Potential confounders affecting the reintubation rate : Discussion on "Reconnection to mechanical ventilation for 1 h after a successful spontaneous breathing trial reduces reintubation in critically ill patients: a multicenter randomized controlled trial", Intensive Care Med, 44(4), 542-543, 201804
  73. Target blood pressure for septic and vasodilatory shock: what is optimal?, Intensive Care Med, 44(4), 548-549, 201804
  74. An emerging frontier in the treatment of acute exacerbation of idiopathic pulmonary fibrosis, Respir Investig, 56(2), 97-99, 201803
  75. Use of proton pump inhibitors is associated with increased mortality due to nosocomial pneumonia in bedridden patients receiving tube feeding, Geriatr Gerontol Int, 18(8), 1215-1218, 201808
  76. Rapid-onset plasma leakage of extracorporeal oxygenation membranes possibly due to hyperbilirubinemia, J Artif Organs, (in press), 201806
  77. Does Dysphagia After Extubation Really Increase Mortality?, Crit Care Med, 46(7), e726-e727, 201807
  78. Should We Abandon APRV in Pediatric ARDS?, Am J Respir Crit Care Med, (in press), 201808
  79. 2018 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations Summary, Resuscitation, S0300-9572(18), 31001-31003, 201811
  80. ★, 2018 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations Summary, Circulation, 2018
  81. ★, Paediatric acute respiratory distress syndrome incidence and epidemiology (PARDIE): an international, observational study., Lancet Respir Med, S2213-2600(18), 30344-30348, 2018
  82. Focusing on Risk Factors of Cardiac Arrest During Intubation in ICU Again., Crit Care Med, 46(11), e1082-e1082, 2018
  83. The western Japan chaotic rainstorm disaster – A brief report from Hiroshima, J Intensive Care, 2018
  84. Serial measurements of KL-6 for monitoring activity and recurrence of interstitial pneumonia with anti-aminoacyl-tRNA synthetase antibody A retrospective cohort study, MEDICINE, 97(49), 201812
  85. Ventilator-associated events: prevalence and mortality in Japan, JOURNAL OF THORACIC DISEASE, 10(12), 6942-6949, 201812
  86. Changes in serum KL-6 levels are associated with the development of chronic lung allograft dysfunction in lung transplant recipients, TRANSPLANT IMMUNOLOGY, 52, 40-44, 201902
  87. ★, Advanced airway interventions for paediatric cardiac arrest: A systematic review and meta-analysis, RESUSCITATION, 138, 114-128, 201905
  88. Comparison of anti-aminoacyl-tRNA synthetase antibody-related and idiopathic non-specific interstitial pneumonia, RESPIRATORY MEDICINE, 152, 44-50, 201906
  89. Confounding factors for the effect of misdiagnosis of site of infection on in-hospital mortality, Crit Care, 23, 294-294, 2019
  90. C-C Motif Chemokine Ligand 15 May Be a Useful Biomarker for Predicting the Prognosis of Patients with Chronic Hypersensitivity Pneumonitis, Respiration, 98, 212-220, 2019
  91. Is lung ultrasonography really useful for diagnosing weaning-induced pulmonary oedema?, Intensive Care Med, 45, 1329-1329, 2019
  92. Impact of inappropriate empiric antimicrobial therapy on mortality in pediatric patients with bloodstream infection: a retrospective observational study, J Chemother, 1-6, 2019
  93. ★, Mechanical Ventilation Management during ECMO for ARDS: An International Multicenter Prospective Cohort, Am J Respir Crit Care, 2019
  94. C-C Motif Chemokine Ligand 15 May Be a Useful Biomarker for Predicting the Prognosis of Patients with Chronic Hypersensitivity Pneumonitis, RESPIRATION, 98(3), 212-220, 201909
  95. Mechanical Ventilation Management during Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome An International Multicenter Prospective Cohort, AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 200(8), 1002-1012, 20191015
  96. High serum potassium level is associated with successful electrical cardioversion for new-onset atrial fibrillation in the intensive care unit: A retrospective observational study, ANAESTHESIA AND INTENSIVE CARE, 47(1), 52-59, 201901
  97. Unique patterns of lower respiratory tract microbiota are associated with inflammation and hospital mortality in acute respiratory distress syndrome, RESPIRATORY RESEARCH, 20(1), 20191106
  98. Retrospective immunohistological study of autopsied lungs in patients with acute exacerbation of interstitial pneumonia managed with extracorporeal membrane oxygenation, JOURNAL OF THORACIC DISEASE, 11(11), 4436-4443, 201911
  99. Decreased intracellular histamine concentration and basophil activation in anaphylaxis, ALLERGOLOGY INTERNATIONAL, 69(1), 78-83, 202001
  100. Immediate Interventions for Presyncope of Vasovagal or Orthostatic Origin: A Systematic Review, PREHOSPITAL EMERGENCY CARE, 24(1), 64-76, 20200102
  101. Baseline High-Resolution CT Findings Predict Acute Exacerbation of Idiopathic Pulmonary Fibrosis: German and Japanese Cohort Study, JOURNAL OF CLINICAL MEDICINE, 8(12), 201912
  102. Neurally adjusted ventilatory assist mitigates ventilator-induced diaphragm injury in rabbits, RESPIRATORY RESEARCH, 20(1), 20191223
  103. Serum high-mobility group box 1 is associated with the onset and severity of acute exacerbation of idiopathic pulmonary fibrosis, RESPIROLOGY, 25(3), 275-280, 202003
  104. Paediatric targeted temperature management post cardiac arrest: A systematic review and meta-analysis, RESUSCITATION, 139, 65-75, 201906
  105. 2019 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations, RESUSCITATION, 145, 95-150, 201912
  106. ★, 2019 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Support; Education, Implementation, and Teams; and First Aid Task Forces, CIRCULATION, 140(24), E826-E880, 20191210
  107. Paediatric acute respiratory distress syndrome incidence and epidemiology (PARDIE): an international, observational study, LANCET RESPIRATORY MEDICINE, 7(2), 115-128, 201902
  108. Impact of inappropriate empiric antimicrobial therapy on mortality in pediatric patients with bloodstream infection: a retrospective observational study, JOURNAL OF CHEMOTHERAPY, 31(7-8), 388-393, 2019
  109. Reduced endogenous secretory RAGE in blood and bronchoalveolar lavage fluid is associated with poor prognosis in idiopathic pulmonary fibrosis, RESPIRATORY RESEARCH, 21(1), 20200611
  110. Prognosis of pathogen-proven acute respiratory distress syndrome diagnosed from a protocol that includes bronchoalveolar lavage: a retrospective observational study, JOURNAL OF INTENSIVE CARE, 8(1), 20200723
  111. ★, Mechanical Ventilation Management during Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome. An International Multicenter Prospective Cohort, Am J Respir Crit Care Med, 200(8), 1002-1012, 2019
  112. Potential confounders for the effect of high-flow nasal cannula oxygen therapy, Crit Care, 23(1), 17-17, 2019
  113. Azathioprine for Connective Tissue Disease-Associated Interstitial Lung Disease, RESPIRATION, 99(8), 628-636, 202009
  114. Serum high-mobility group box 1 as a predictive marker for cytotoxic chemotherapy-induced lung injury in patients with lung cancer and interstitial lung disease, RESPIRATORY MEDICINE, 172, 202010
  115. Extent of pulmonary fibrosis on high-resolution computed tomography is a prognostic factor in patients with pleuroparenchymal fibroelastosis, RESPIRATORY INVESTIGATION, 58(6), 465-472, 202011
  116. Japan ECMOnet for COVID-19: telephone consultations for cases with severe respiratory failure caused by COVID-19, JOURNAL OF INTENSIVE CARE, 8(1), 20200407
  117. Prognostic relevance and inter-observer reliability of chest-imaging in pediatric ARDS: a pediatric acute respiratory distress incidence and epidemiology (PARDIE) study, INTENSIVE CARE MEDICINE, 46(7), 1382-1393, 202007
  118. Predicting Mortality in Children With Pediatric Acute Respiratory Distress Syndrome: A Pediatric Acute Respiratory Distress Syndrome Incidence and Epidemiology Study, CRITICAL CARE MEDICINE, 48(6), E514-E522, 202006
  119. Pediatric Life Support 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations, RESUSCITATION, 156, A120-A155, 202011
  120. Pediatric Life Support 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations, CIRCULATION, 142, S140-S184, 20201020
  121. Better Management of Delirium by Family Members., Crit Care Med, 48(11), e1161-e1162, 2020
  122. Early PaCO2 Changes after Initiating Extracorporeal Membrane Oxygenation: Considerations for Future Research, Am J Respir Crit Care Med, 202(11), 1600-1601, 2020
  123. Esophageal pressure and potential confounders for evaluating patient-ventilator asynchrony, J Crit Care, 60, 344, 2020
  124. Save the ICU and save lives during the COVID-19 pandemic, J Intensive Care, 8, 40, 2020
  125. Nationwide system to centralize decisions around extracorporeal membranous oxygenation use for severe COVID-19 pneumonia in Japan, Acute Med Surg, 7(1), e510, 2020
  126. Nationwide system to centralize decisions around ECMO use for severe COVID-19 pneumonia in Japan, J Intensive Care, 8, 29, 2020
  127. Potential Confounders for Applying a Novel Sepsis Care Quality Improvement Program, Crit Care Med, 48(2), e161-e162, 2020

Publications such as books

  1. 2016, 呼吸器ケア, "肺にやさしい換気"がわかる 人工呼吸管理中のモニタリングシステム, メディカ出版, 2016, 2016, Scholarly Book, Single work
  2. 2016, 日本外科感染症学会雑誌, 誤嚥と誤嚥性肺炎について考える, 日本外科感染症学会, 2016, 2016, Scholarly Book, Joint work
  3. 2016, 救急・集中治療, 中心静脈カテーテル抜去時のカテーテル培養をルーチンで行う?, 総合医学社, 2016, 2016, Scholarly Book, Joint work

Invited Lecture, Oral Presentation, Poster Presentation

  1. Association between the severity and coagulopathy in anaphylaxis patients, Satoshi Yamaga, Yuhki Yanase, Kaori Ishii, Koji Hosokawa, Shinichiro Ohshimo, Nobuaki Shime, Michihiro Hide, 2020/03, Without Invitation, English
  2. Sepsis: What should we do in the first 3 hours?, Shinichiro Ohshimo, 2020/03, With Invitation, Japanese
  3. Impact of protocolized diagnostic work-up including Bronchoalveolar lavage on mortality of acute respiratory distress patients: a retrospective observational study, Michihito Kyo, Koji Hosokawa, Shinichiro Ohshimo, Yoshiko Kida, Yuko Tanabe, Kohei Ota, Nobuaki Shime, The 20th Japanese Society of Intensive Care Medicine (JSICM) - Korean Society of Critical Care Medicine (KSCCM) Joint Congress, 2020/03, Without Invitation, English
  4. Recent Advances in the Respiratory ECMO, Shinichiro Ohshimo, The 8th Meeting of the International Federation for Artificial Organs (IFAO 2019) The 57th Annual Meeting of the Japanese Society for Artificial Organs (JSAO 2019), 2019/11, With Invitation, English
  5. Current ECMO in Japan, Shinichiro Ohshimo, Asia-Pacific Extracorporeal Life Support Organization 2019 Conference, 2019/11, With Invitation, English
  6. Different aspects of diffuse lung diseases in intensive care unit and respiratory department, Shinichiro Ohshimo, Yoshiko Kida, Chihiro Hirano, Kazuya Kikutani, Michihito Kyo, Takahiro Inagawa, Kohei Ota, Koji Hosokawa, Kakuhiro Yamaguchi, Yasushi Horimasu, Shintaro Miyamoto, Hiroshi Iwamoto, Kazunori Fujitaka, Hironobu Hamada, Francesco Bonella, Josune Guzman, Ulrich Costabel, Noboru Hattori, Nobuaki Shime, WASOG International conference on Sarcoidosis and Interstitial Lung Diseases 2019, 2019/10, Without Invitation, English
  7. Fine crackles quantitative value can help the diagnosis of interstitial lung diseases – Clinical utility of the innovative analyzing system of respiratory sounds, Yasushi Horimasu, Shinichiro Ohshimo, Kakuhiro Yamaguchi, Shinjiro Sakamoto, Takeshi Masuda, Taku Nakashima, Shintaro Miyamoto, Hiroshi Iwamoto, Takuma Sadamori, Kazunori Fujitaka, Hironobu Hamada, Nobuaki Shime, Noboru Hattori, European Respiratory Society International Congress 2019, 2019/09, Without Invitation, English
  8. Imbalance in the oral bacterial flora as a risk factor for acute exacerbation in idiopathic pulmonary fibrosis, Shinichiro Ohshimo, Hiromi Nishi, Koji Hosokawa, Yasushi Horimasu, Shintaro Miyamoto, Hiroshi Iwamoto, Hironobu Hamada, Hiroyuki Kawaguch, Francesco Bonella, Josune Guzman, Ulrich Costabel, Noboru Hattori, Nobuaki Shime, European Respiratory Society International Congress 2019, 2019/09, Without Invitation, English
  9. Clinical utility of CCL15 as a prognostic biomarker for hypersensitivity pneumonitis, M. Watanabe, Y. Horimasu, H. Iwamoto, K. Yamaguchi, S. Sakamoto, T. Masuda, T. Nakashima, S. Miyamoto, S. Ohshimo, K. Fujitaka, H. Hamada, N. Kohno, N. Hattori, European Respiratory Society International Congress 2019, 2019/09, Without Invitation, English
  10. ECMO Cannulation Simulation, Shinichiro Ohshimo, The 41st Annual Meeting of the Japanese Society of Respiratory Care Medicine (JSRCM41) pre-congress seminar, 2019/08, With Invitation, English
  11. Association between appropriate empiric antimicrobial therapy and mortality from bloodstream infections in the intensive care unit, Satoshi Yamaga, Nobuaki Shime, Shinichiro Ohshimo, The 3rd JSICM/TSCCM Joint Congress, 2019/03, Without Invitation, English
  12. Association between appropriate empiric antimicrobial therapy and mortality from bloodstream infections in the intensive care unit, Satoshi Yamaga, Nobuaki Shime, Shinichiro Ohshimo, The 46th Annual Meeting of the Japanese Society of Intensive Care Medicine, 2019/03, Without Invitation, English
  13. ECMO Training Program in Japan, Tomoyuki Endo, Shinichiro Oshimo, The 3rdTSCCM/JSICM Joint Congress, 2019/03, With Invitation, English
  14. Utility of continuous monitoring and visualizing system for respiratory sounds, Kazuya Kikutani, Shinichiro Ohshimo, Shingo Ohki, Hiroshi Giga, Satoshi Yamaga, Takuma Sadamori, Nobuaki Shime, The 3rd JSICM/TSCCM Joint Congress, 2019/03, Without Invitation, English
  15. Modified GAP stage as a predictor of acute exacerbation in idiopathic pulmonary fibrosis, Shinichiro Ohshimo, Yoshiko Kida, Michihito Kyo, Koji Hosokawa, Yasushi Horimasu, Shintaro Miyamoto, Hiroshi Iwamoto, Hironobu Hamada, Noboru Hattori, Francesco Bonella, Josune Guzman, Ulrich Costabel, Nobuaki Shime, European Respiratory Society International Congress 2018, 2018/09, Without Invitation, English
  16. Modified GAP stage as a predictor of acute exacerbation in idiopathic pulmonary fibrosis, Shinichiro Ohshimo, Yoshiko Kida, Michihito Kyo, Koji Hosokawa, Yasushi Horimasu, Shintaro Miyamoto, Hiroshi Iwamoto, Hironobu Hamada, Noboru Hattori, Francesco Bonella, Josune Guzman, Ulrich Costabel, Nobuaki Shime, European Respiratory Society International Congress 2018, 2018/09, Without Invitation, English
  17. Clinical relevance of antinuclear antibodies (ANA) in patients with hypersensitivity pneumonitis (HP): a single centre experience., F. Bonella, J. Sennekamp, M. Joest, M. Rolke, S. Ohshimo, J. Guzman, C. Taube, U. Costabel, American Thoracic Society International Conference 2018, 2018/05, Without Invitation, English
  18. Extent of the honeycombing area and the presence of traction bronchiectasis are risk factors for a poor prognosis in patients with pleuroparenchymal fibroelastosis, Masashi Namba, Takeshi Masuda, Kakuhiro Yamaguchi, Shinjiro Sakamoto, Yasushi Horimasu, Taku Nakashima, Shintarou Miyamoto, Hiroshi Iwamoto, Shinichiro Ohshimo, Kazunori Fujitaka, Hironobu Hamada, Noboru Hattori, American Thoracic Society International Conference 2018, 2018/05, Without Invitation, English
  19. Clinical Relevance Of Antinuclear Antibodies (ANA) In Patients With Hypersensitivity Pneumonitis (HP): A Single Centre Experience., F. Bonella, J. Sennekamp, M. Joest, M. Rolke, S. Ohshimo, J. Guzman, C. Taube, U. Costabel, American Thoracic Society International Conference 2018, 2018/05, Without Invitation, English
  20. Extent of the honeycombing area and the presence of traction bronchiectasis are risk factors for a poor prognosis in patients with pleuroparenchymal fibroelastosis, Masashi Namba, Takeshi Masuda, Kakuhiro Yamaguchi, Shinjiro Sakamoto, Yasushi Horimasu, Taku Nakashima, Shintarou Miyamoto, Hiroshi Iwamoto, Shinichiro Ohshimo, Kazunori Fujitaka, Hironobu Hamada, Noboru Hattori, American Thoracic Society International Conference 2018, 2018/05, Without Invitation, English
  21. Bronchoalveolar lavage as a diagnostic and prognostic tool in acute respiratory failure, Yusuke Iwasaki, Yoshiko Kida, Michihito Kyo, Koji Hosokawa, Shinichiro Ohshimo, Nobuaki Shime, ISICEM 2018-38th International Symposium on Intensive Care and Emergency Medicine, 2018/03, Without Invitation, English
  22. Changes in end-of-life practices (EOLP) in European intensive care units (ICUs): The Ethicus study, C.L. Sprung, C. Hartog, B. Ricou, A. Michalsen, C. Feldman, P. Levin, M. Baras, M. Weiss, HH. Buelow, A. Avian for the Ethicus II investigators (Shinichiro Ohshimo), ISICEM 2018-38th International Symposium on Intensive Care and Emergency Medicine, 2018/03, Without Invitation, English
  23. End-of-life practices (EOLP) in worldwide intensive care units (ICUs): The Ethicus study, A. Avidan, C.L. Sprung, B. Ricou, A. Michalsen, C. Feldman, M. Anstey, M. Baras, M. Weiss, HH. Buelow, C. Hartog for the Ethicus II investigators (Shinichiro Ohshimo), ISICEM 2018-38th International Symposium on Intensive Care and Emergency Medicine, 2018/03, Without Invitation, English
  24. Bronchoalveolar lavage as a diagnostic and prognostic tool in acute respiratory failure, Yusuke Iwasaki, Yoshiko Kida, Michihito Kyo, Koji Hosokawa, Shinichiro Ohshimo, Nobuaki Shime, ISICEM 2018-38th International Symposium on Intensive Care and Emergency Medicine, 2018/03, Without Invitation, English
  25. End-of-life practices (EOLP) in worldwide intensive care units (ICUs): The Ethicus study, A. Avidan, C.L. Sprung, B. Ricou, A. Michalsen, C. Feldman, M. Anstey, M. Baras, M. Weiss, HH. Buelow, C. Hartog for the Ethicus II investigators, 38th International Symposium on Intensive Care and Emergency Medicine, 2018/03, With Invitation, English
  26. Emerging ventilation strategy during cardiopulmonary resuscitation, Shinichiro Ohshimo, The 45th Annual Meeting of the Japanese Society of Intensive Care Medicine, 2018/02, With Invitation, English
  27. Update in the prevention and the diagnosis of ventilator-associated pneumonia, Shinichiro Ohshimo, The 45th Annual Meeting of the Japanese Society of Intensive Care Medicine, 2018/02, With Invitation, Japanese
  28. Rhabdomyolysis induced by hyperthermia associated with thermoregulatory failure in a patient with spinal cord injury, Junki Ishii, Yoshiko Kida, Shinichiro Ohshimo, Yuki Uchida, Yusuke Iwasaki, Kazuhiro Koyama, Satoshi Yamaga, Kohei Ota, Nobuaki Shime, The 18th Joint Scientific Congress of the JSICM and KSCCM, 2018/02, Without Invitation, English
  29. Impact of lower respiratory tract microbiome in ARDS, 2018/02, Without Invitation, Japanese
  30. Conservative oxygen therapy targeting SpO2 of 94-98% is favorable, Shinichiro Ohshimo, 2018/02, With Invitation, Japanese
  31. Actions by JSICM Crisis Management Committee for the mass casualty management in the ICU, 2018/02, With Invitation, Japanese
  32. Emerging ventilation strategy during cardiopulmonary resuscitation, Shinichiro Ohshimo, 2018/02, With Invitation, English
  33. Bronchoalveolar lavage as a diagnostic and prognostic tool in acute respiratory failure, Yusuke Iwasaki, Yoshiko Kida, Michihito Kyo, Koji Hosokawa, Shinichiro Ohshimo, Nobuaki Shime, ISICEM 2018-38th International Symposium on Intensive Care and Emergency Medicine, 2018, Without Invitation, English
  34. Changes in end-of-life practices (EOLP) in European intensive care units (ICUs): The Ethicus study, C.L. Sprung, C. Hartog, B. Ricou, A. Michalsen, C. Feldman, P. Levin, M. Baras, M. Weiss, HH. Buelow, A. Avian for the Ethicus II investigators (Ohshimo S), ISICEM 2018-38th International Symposium on Intensive Care and Emergency Medicine, 2018, Without Invitation, English
  35. End-of-life practices (EOLP) in worldwide intensive care units (ICUs): The Ethicus study, A. Avidan, C.L. Sprung, B. Ricou, A. Michalsen, C. Feldman, M. Anstey, M. Baras, M. Weiss, HH. Buelow, C. Hartog for the Ethicus II investigators (Ohshimo S), 2018, Without Invitation, English
  36. ECMO, Shinichiro Ohshimo, The 11th forum of diffuse lung diseases, 2017/12/16, With Invitation, Japanese
  37. Impact of Inappropriate Empiric Antibiotic Therapy on Mortality in Pediatric Patients with Bloodstream Infection, Michihito Kyo1, Shinichiro Ohshimo1, Tadashi Kosaka2, Naohisa Fujita2 and Nobuaki Shime1, The 30th International Congress of Chemotherapy and Infection 2017, 2017/11, Without Invitation, English
  38. A case of Capnocytophaga infections complicated with purpura fulminans and disseminated intravascular coagulation, Yusuke Okazaki, Yoshiko Kida, Yuko Tanabe, Kei Suzuki, Shinichiro Ohshimo, Nobuaki Shime, 2017/11, Without Invitation, Japanese
  39. Extracorporeal membrane oxygenation for 2016 influenza-associated acute respiratory failure in Japan, Shinichiro Ohshimo, Nobuaki Shime, Satoshi Nakagawa, Osamu Nishida, Shinhiro Takeda; Committee of Japan ECMO project, Asia-Pacific ELSO Conference 2017, 2017/10, With Invitation, English
  40. Association between survival rates and detailed underlying diseases in patients who underwent ECMO: Report from the Japanese Registry of Respiratory ECMO, Toshiyuki Aokage1, Yuji Fujino2, Shinichiro Ohshimo3, Osamu Nishida4, Shinhiro Takeda5, Kenichi Matsuda6; Committee of ECMO project, Asia-Pacific ELSO Conference 2017, 2017/10, Without Invitation, English
  41. Acute respiratory failure in ILD: diagnosis and management, Shinichiro Ohshimo, WASOG 2017 International conference on Sarcoidosis and Interstitial Lung Diseases (ILD), 2017/10, With Invitation, English
  42. Corticosteroids are not always useful for ARDS, Shinichiro Ohshimo, The 45th Annual Meeting of the Japanese Association for Acute Medicine, 2017/10, With Invitation, Japanese
  43. Utility of intracellular histamine concentration in anaphylaxis, The 45th Annual Meeting of the Japanese Association for Acute Medicine, 2017/10, Without Invitation, Japanese
  44. Accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: A study of 404 pulmonologists from 57 countries., Simon Walsh, David Hansell, Toby Maher, Richard Nusser, Margaret Wilsher, Venerino Poletti, Carlo Vancheri, Luca Richeldi, Paolo Spagnolo, Sara Tomassetti, Vincent Cottin, Bruno Crestani, Dominiue Valeyre, Hilario Nunes, Kevin Brown, Brett Ley, Fernando Martinez, Ganesh Raghu, Kevin Flaherty, Jan C. Grutters, Marlies Wijsenbeek, Hiroyuki Taniguchi, Yoshikazu Inoue, Yasuhiro Kondoh, Moises Selman, Tamera Corte, Ian Glaspole, Martin Kolb, Kerri Johannson, Chris Ryerson, Elisabeth Bendstrup, António Morais, Maria Molina Molina, Wim Wuyts, Juergen Behr, Michael Kreuter, Katerina Antoniou, Athol Wells, George Margaritopoulos, Maria Kokosi, Vasilis Kouranos, Eoin Judge; the IPF project (Shinichiro Ohshimo), European Respiratory Society (ERS) International Congress 2017, 2017/09, Without Invitation, English
  45. Agreement between pulmonologists for the diagnosis of interstitial lung disease: a study of 404 pulmonologists from 57 countries., Simon Walsh, David Hansell, Toby Maher, Richard Nusser, Margaret Wilsher, Venerino Poletti, Carlo Vancheri, Luca Richeldi, Paolo Spagnolo, Sara Tomassetti, Vincent Cottin, Bruno Crestani, Dominiue Valeyre, Hilario Nunes, Kevin Brown, Brett Ley, Fernando Martinez, Ganesh Raghu, Kevin Flaherty, Jan C. Grutters, Marlies Wijsenbeek, Hiroyuki Taniguchi, Yoshikazu Inoue, Yasuhiro Kondoh, Moises Selman, Tamera Corte, Ian Glaspole, Martin Kolb, Kerri Johannson, Chris Ryerson, Elisabeth Bendstrup, António Morais, Maria Molina Molina, Wim Wuyts, Juergen Behr, Michael Kreuter, Katerina Antoniou, Athol Wells, George Margaritopoulos, Maria Kokosi, Vasilis Kouranos, Eoin Judge; the IPF project (Shinichiro Ohshimo), European Respiratory Society (ERS) International Congress 2017, 2017/09, Without Invitation, English
  46. Extracorporeal membrane oxygenation for the treatment of acute exacerbation of interstitial lung diseases, Shinichiro Ohshimo1,2, Yoshiko Kida1, Michihito Kyo1, Yasushi Horimasu2, Hiroshi Iwamoto2, Kazunori Fujitaka2, Hironobu Hamada2, Francesco Bonella3, Josune Guzman4, Ulrich Costabel3, Nobuaki Shime1, Noboru Hattori2, European Respiratory Society (ERS) International Congress 2017, 2017/09, Without Invitation, English
  47. Utility of electronic stethoscope in remote areas medical, Giga H, Ishitoya K, Sadamori T, Kikutani K, Shimatani T, Ohshimo S, Shime N, Japanese Telemedicine and Telecare Association 2017, 2017/09, Without Invitation, Japanese
  48. How to develop the ARDS clinical practice guideline 2016, Shinichiro Ohshimo, Minds 20th Clinical practice guideline workshop, 2017/08/26, With Invitation, Japanese
  49. Helicobacter pylori as a risk factor for acute exacerbation in idiopathic pulmonary fibrosis, Shinichiro Ohshimo 1, Hiromi Nishi 2, Yasushi Horimasu 3, Hiroshi Iwamoto 3, Hironobu Hamada 3, Noboru Hattori 3, Nobuoki Kohno 3 , Francesco Bonella 4, Josune Guzman 5, Ulrich Costabel 4, Nobuaki Shime 1, American Thoracic Society 2017 International Conference, 2017/05, Without Invitation, English
  50. Accuracy of a Clinical Diagnosis of Idiopathic Pulmonary Fibrosis: A Study of 275 Pulmonologists from 54 Countries, Simon L.F. Walsh, David Hansell , Kevin R. Flaherty , Margaret Wilsher , Richard Nusser , Venerino Poletti , Fernando J. Martinez , Elisabeth Bendstrup , Kevin K. Brown , Hiroyuki Taniguchi , Yasuhiro Kondoh , Bruno Crestani , Vincent Cottin , Dominique Valeyre , Hilario Nunes , Jan C. Grutters , Luca Richeldi , Toby M. Maher , Carlo Vancheri , Maria Kokosi , Christopher J. Ryerson , Kerri A. Johannson , Brett J. Ley , Eoin P. Judge , George Margaritopoulos , Michael Kreuter , Juergen Behr , António Morais , Marlies Wijsenbeek , Tamera J. Corte , Ian Glaspole , Paolo Spagnolo , Sara Tomassetti , Maria Molina-Molina , Moises Selman , Vasilis Kouranos , Wim A. Wuyts , Mark Jones , Athol U. Wells; the IPF project (Shinichiro Ohshimo), American Thoracic Society 2017 International Conference, 2017/05, Without Invitation, English
  51. Agreement between pulmonologists for the diagnosis of interstitial lung disease: a study of 275 pulmonologists from 54 countries, Simon L.F. Walsh, David Hansell , Kevin R. Flaherty , Margaret Wilsher , Richard Nusser , Venerino Poletti , Fernando J. Martinez , Elisabeth Bendstrup , Kevin K. Brown , Hiroyuki Taniguchi , Yasuhiro Kondoh , Bruno Crestani , Vincent Cottin , Dominique Valeyre , Hilario Nunes , Jan C. Grutters , Luca Richeldi , Toby M. Maher , Carlo Vancheri , Maria Kokosi , Christopher J. Ryerson , Kerri A. Johannson , Brett J. Ley , Eoin P. Judge , George Margaritopoulos , Michael Kreuter , Juergen Behr , António Morais , Marlies Wijsenbeek , Tamera J. Corte , Ian Glaspole , Paolo Spagnolo , Sara Tomassetti , Maria Molina-Molina , Moises Selman , Vasilis Kouranos , Wim A. Wuyts , Mark Jones , Athol U. Wells; the IPF project (Shinichiro Ohshimo), American Thoracic Society 2017 International Conference, 2017/05, Without Invitation, English
  52. Respiratory management in ICU & Emergency department: (1) Mechanical ventilation in the new era, Shinichiro Ohshimo, The 33rd Annual Meeting of the Japanese Society for Therapeutics & Engineering, 2017/04, With Invitation, Japanese
  53. Respiratory management in ICU & Emergency department: (1) Management of acute respiratory failure using extracorporeal membrane oxygenation, Shinichiro Ohshimo, The 33rd Annual Meeting of the Japanese Society for Therapeutics & Engineering, 2017/04, With Invitation, Japanese
  54. Ground-glass opacity and fibrosis on HRCT as risk factors of acute exacerbation of IPF: an international multicenter study, Chihiro Hirano, Shinichiro Ohshimo1, Hilmar Kuehl2, Daisuke Komoto3, Yasushi Horimasu1, Hiroshi Iwamoto1, Hironobu Hamada1, Noboru Hattori1, Ulrich Costabel4, Nobuoki Kohno1, The 57th Annual Meeting of the Japanese Respiratory Society, 2017/04, Without Invitation, English
  55. Exposure and ILD: Exploring novel therapy, Shinichiro Ohshimo, Asia-Pacific Regional Conference 2017, 2017/03/24, With Invitation, English
  56. Effect of Electrical Cardioversion for New-Onset Atrial Fibrillation in Intensive Care Unit, 2017/03, Without Invitation, Japanese
  57. Protein expression profile in acute exacerbation of interstitial pneumonia supported on V-V ECMO, Yoshiko Kida, Shinichiro Ohshimo, Michihito Kyo, AMATYA Jeet Vishwa, Yukio Takeshima, Nobuaki Shime, Annual Congress 46th Critical Care Congress, 2017/01, Without Invitation, English, Honolulu, Hawaii, USA
  58. The validation of qSOFA criteria for sepsis, Michihito Kyo, Shinichiro Ohshimo, Yoshiko Kida, Nobuaki Shime, Annual Congress 46th Critical Care Congress, 2017/01, Without Invitation, English, Honolulu, Hawaii, USA
  59. The experiences of physical therapy for the patients with veno-venous extracorporeal membrane oxygenation in Hiroshima university hospital, SARADA K, TAITO S, SEKIKAWA K, OHSHIMO S, OTA K, HIROHASHI N, UEDA K, MIKAMI Y, KIMURA H, SHIME N, ITO Y, 13th Asian Confederation of Physical Therapy: ACPT Congress 2016, 2016/10, Without Invitation, English
  60. The utilization of information and communication technology in the acute phase of Kumamoto earthquake, 2016/10, Without Invitation, Japanese
  61. Detection of anti DFS70 antibodies in patients with interstitial lung disease (ILD) with and without connective tissue disease (CTD), Bonella F, Lyu Y, Theegarten D, Boerner E, Wessendorf TE, Ohshimo S, Guzman J, Costabel U, Kreuter M., ERS International Congress, 2016/09, Without Invitation, English, London, UK
  62. ARDSシンポジウム, 大下慎一郎, 第38回 日本呼吸療法医学会学術集会, 2016/07, With Invitation, Japanese, Nagoya, Japan
  63. Prognostic factors for critically ill patients with Staphylococcus aureus bacteremia, 大下 慎一郎, 木田 佳子, 島谷 竜俊, 鳥越 勇佑, 鈴木 慶, 山賀 聡之, 廣橋 伸之, 志馬 伸朗, 2016/07, Without Invitation, Japanese
  64. FAM13A polymorphism as a prognostic factor in Japanese patients with idiopathic pulmonary fibrosis, Hirano C, Ohshimo S, Horimasu Y, Iwamoto H, Fujitaka K, Hamada H, Hattori N, Bonella F, Guzman J, Costabel U, Kohno N., American Thoracic Society International Conference 2016, 2016/05, Without Invitation, English, San Francisco, CA
  65. FAM13A polymorphism as a prognostic factor in Japanese patients with idiopathic pulmonary fibrosis, Hirano C, Ohshimo S, Horimasu Y, Iwamoto H, Hamada H, Hattori N, Bonella F, Guzman J, Costabel U, Kohno N., 2016/04, Without Invitation, English, Kyoto, Japan
  66. Analysis of autopsy findings in patients with acute respiratory failure supported on V-V ECMO, Yoshiko Kida, Shinichiro Ohshimo, Michihito Kyo, Tatutoshi Shimatani, Nobuyuki Hirohashi, Nobuaki Shime, The 35th Annual Conference of the Korean Society of Critical Care Medicine, 2016/04, Without Invitation, English
  67. Successful use of VAV ECMO in a patient with respiratory failure complicated by myocarditis, Michihito Kyo, Shinichiro Ohshimo, Yoshiko Kida, Tatsutoshi Shimatani, Yusuke Torikoshi, Kei Suzuki, Satoshi Yamaga, Nobuyuki Hirohashi, Nobuaki Shime, The 35th Annual Conference of the Korean Society of Critical Care Medicine, 2016/04, Without Invitation, English
  68. Optimal Volume and Substance in Intraesophageal Balloon Catheter for Esophageal Pressure Measurement, Tatsutoshi Shimatani, Shinichiro Ohshimo, Michihito Kyo, Yoshiko Kida, Nobuaki Shime, The 35th Annual Conference of the Korean Society of Critical Care Medicine, 2016/04, Without Invitation, English
  69. マムシ咬傷により発症した破傷風の一例, 岡崎裕介, 山賀聡之, 島谷竜俊, 京道人, 小山和宏, 稲川嵩紘, 鳥越勇佑, 鈴木慶, 木田佳子, 田邉優子, 太田浩平, 大谷直嗣, 貞森拓磨, 津村龍, 大下慎一郎, 岩崎泰昌, 廣橋伸之, 志馬伸朗, 第33回日本集中治療医学会 中国四国地方会, 2016/02/20, Without Invitation, Japanese, Hiroshima, Japan
  70. 人工呼吸器離脱にNAVAが有用であった2症例, 木田佳子, 大下慎一郎,志馬伸朗, 第43回日本集中治療医学会学術集会 NAVAミーティング, 2016/02/12, Without Invitation, Japanese, Nagoya, Japan
  71. 集中治療室における黄色ブドウ球菌敗血症患者の予後因子, 京 道人, 木田 佳子、大下 慎一郎、鈴木 慶、山賀 聡之、廣橋 伸之、志馬 伸朗, 第43回日本集中治療医学会学術集会, 2016/02, Without Invitation, Japanese, Kobe, Japan
  72. 呼吸音自動解析能を有する新たな電子聴診器の開発, 山賀聡之, 大下慎一郎,貞森拓磨,儀賀普嗣,岩崎泰昌,廣橋伸之,志馬伸朗, 第43回日本集中治療医学会学術集会, 2016/02, Without Invitation, Japanese, Kobe, Japan
  73. ECMO使用患者における予後因子としての赤血球分布幅, 大下慎一郎, 木田佳子, 京 道人,島谷竜俊,鳥越勇佑,鈴木 慶,山賀聡之,岩崎泰昌,廣橋伸之,志馬伸朗, 第43回日本集中治療医学会学術集会, 2016/02, Without Invitation, Japanese, Kobe, Japan
  74. Red cell distribution width as a prognostic factor for patients supported with ECMO, 2016/02, Without Invitation, Japanese
  75. 救命救急センターにおける黄色ブドウ球菌菌血症の予後関連因子についての検討, 京 道人, 木田佳子, 大下慎一郎, 廣橋伸之, 志馬伸朗, 第38回広島感染症研究会, 2015/11/07, Without Invitation, Japanese, Hiroshima
  76. ヘリコプター2機による連携で対応した複数傷病者の一事案, 鳥越勇佑, 大谷直嗣, 京道人, 島谷竜俊, 鈴木慶, 山賀聡之, 太田浩平, 大下慎一郎, 津村龍, 岩崎泰昌, 廣橋伸之, 儀賀普嗣, 多田昌弘, 竹崎亨, 山野上敬夫, 第22回日本航空医療学会総会, 2015/11, Without Invitation, Japanese, 前橋,群馬
  77. 嘔吐マネキンモデルに対する 救急救命士による気管挿管における Airway ScopeとMacintosh型喉頭鏡の比較, 鈴木 慶, 楠 真二,貞森 拓磨,田邊 優子,板井純治,大下慎一郎,廣橋伸之,志馬伸朗, 第43回 日本救急医学会総会・学術集会, 2015/10, Without Invitation, Japanese, Tokyo, Japan
  78. シアン化カリウムによる急性中毒を救命し得た1症例, 田邉優子, 山賀聡之,佐藤智人,稲川嵩紘,鈴木慶,矢野佳子,太田浩平,大谷直嗣,大下慎一郎,岩崎泰昌,廣橋伸之, 第43回 日本救急医学会総会・学術集会, 2015/10, Without Invitation, Japanese, Tokyo, Japan
  79. 災害現場での無人航空機(ドローン)による映像伝送の有用性, 島谷竜俊, 貞森拓磨、鈴木慶、木田佳子、山賀聡之、太田浩平、田邉優子、大谷直嗣、大下慎一郎、岩崎泰昌、廣橋伸之, 第43回 日本救急医学会総会・学術集会, 2015/10, Without Invitation, Japanese, Tokyo, Japan
  80. Comparative Analysis of Multiple Gene Polymorphisms for Acute Exacerbation of Idiopathic Pulmonary Fibrosis, Ohshimo S, European Respiratory Society (ERS) International Congress 2015, 2015/09, Without Invitation, English, Amsterdam, Netherlands
  81. Serum KL-6 as a biomarker to assess response to azathioprine in connective tissue disease associated lung disease (CTD-ILD), Boerner EB, Wessendorf TE, Ohshimo S, Costabel U, Bonella F., European Respiratory Society International Congress 2015, 2015/09, Without Invitation, English, Amsterdam, Netherlands
  82. MUC1 gene polymorphism and serum KL-6 in lung adenocarcinoma, Horimasu Y, Ishikawa N, Tanaka S, Iwamoto H, Ohshimo S, Fujitaka K, Hattori N, Hamada H, Kohno N., European Respiratory Society International Congress 2015, 2015/09, Without Invitation, English, Amsterdam, Netherlands
  83. Benefit of veno-venous ECMO in patients with acute exacerbation of interstitial pneumonia, Ohshimo S, Asia-Pacific ELSO 2015 - 2nd Conference of Asia-Pacific Chapter of Extracorporeal Life Support Organization, 2015/07, Without Invitation, English, Kyoto, Japan
  84. Analysis of autopsy findings in patients with acute respiratory failure supported on V-V ECMO, Kida Y, Shinichiro Ohshimo, Kohei Ota, Kei Suzuki, Satoshi Yamaga, Yasumasa Iwasaki, Nobuyuki Hirohashi, Koichi Tanigawa, Asia-Pacific ELSO 2015 - 2nd Conference of Asia-Pacific Chapter of Extracorporeal Life Support Organization, 2015/07, Without Invitation, English, Kyoto, Japan
  85. Successful use of V-VA ECMO in a patient with respiratory failure complicated by myocarditis, Kyo M, Shinichiro Ohshimo, Yoshiko Kida, Kohei Ota, Kei Suzuki, Satoshi Yamaga, Yasumasa Iwasaki, Nobuyuki Hirohashi, Koichi Tanigawa, Asia-Pacific ELSO 2015 - 2nd Conference of Asia-Pacific Chapter of Extracorporeal Life Support Organization, 2015/07, Without Invitation, English, Kyoto, Japan
  86. 心筋炎に伴う呼吸不全に対してV-VA ECMOを施行した一例, 京 道人, 大下慎一郎,儀賀普嗣,島谷竜俊,小山和宏,稲川嵩紘,鈴木 慶,矢野佳子,山賀聡之,田邉優子,太田浩平,宇根一暢,大谷直嗣,貞森拓磨,津村 龍,岩崎泰昌,廣橋伸之,谷川攻一, 第37回日本呼吸療法医学会総会, 2015/07, Without Invitation, Japanese, Tokyo, Japan
  87. 日本人の間質性肺炎急性増悪症例における体外式膜型人工肺(ECMO)の有用性, 大下慎一郎, 木田佳子, 太田浩平, 京 道人, 島谷竜俊, 儀賀普嗣, 小山和宏, 稲川嵩紘, 鈴木 慶, 山賀聡之, 田邉優子, 大谷直嗣, 貞森拓磨, 宇根一暢, 津村 龍, 岩崎泰昌, 廣橋伸之, 服部 登, 河野修興, 谷川攻一, 第37回日本呼吸療法医学会総会, 2015/07, Without Invitation, Japanese, Tokyo, Japan
  88. ARDSの疫学:患者の生命予後は改善されたのか?, 大下慎一郎, 第37回日本呼吸療法医学会総会, 2015/07, With Invitation, Japanese, Tokyo, Japan
  89. V-V ECMOを使用した成人急性呼吸不全症例における剖検診断の検討, 木田佳子, 大下慎一郎, 太田浩平, 山賀聡之, 鈴木慶, 田邉優子, 稲川嵩紘, 小山和宏, 儀賀普嗣, 京道人, 島谷竜俊, 宇根一暢, 大谷直嗣, 岩崎泰昌, 廣橋伸之, 河野修興, 谷川攻一, 第37回日本呼吸療法医学会総会, 2015/07, Without Invitation, Japanese, Tokyo, Japan
  90. Growth Differentiation Factor-15 (GDF-15) as Prognostic Factor in German Patients with Idiopathic Pulmonary Fibrosis, Ohshimo S, American Thoracic Society 2015 International Conference, 2015/05, Without Invitation, English, Denver, CO
  91. Serum KL-6 levels correlate with response to pirfenidone in idiopathic pulmonary fibrosis, F. Bonella, S. Ohshimo, E. Boerner, J. Guzman, T.E. Wessendorf, U. Costabel, American Thoracic Society 2015 International Conference, 2015/05, Without Invitation, English, Denver, CO
  92. 複数傷病者事案に対するヘリコプター救急医療活動について, 大谷直嗣, 鈴木慶、山賀聡之、田村朋子、太田浩平、大下慎一郎、津村龍、岩崎泰昌、廣橋伸之、板井純治、多田昌弘、竹崎亨、楠真二、山野上敬夫、谷川攻一, 第31回日本救急医学会 中国四国地方会, 2015/05, Without Invitation, Japanese, Tokushima, Japan
  93. KL-6 changes in serum could predict the development of chronic lung allograft dysfunction in lung transplant recipients, V. Besa, F. Bonella , S. Ohshimo, G. Weinreich , U.Costabel, M. Kamler, H. Teschler, U. Sommerwerck, ISHLT 35th Annual Meeting and Scientific Sessions, 2015/04, Without Invitation, English, Nice, France
  94. Growth differentiation factor-15 (GDF-15) as prognostic factor in Caucasians with idiopathic pulmonary fibrosis, Ohshimo S, Hamai K, Bonella F, Yamaoka C, Horimasu Y, Iwamoto H, Ishikawa N, Fujitaka K, Murai H, Hamada H, Hattori N, Hirohashi N, Tanigawa K, Guzman J, Costabel U, Kohno N., 第55回日本呼吸器学会学術講演会, 2015/04, Without Invitation, English, Tokyo, Japan
  95. HRCT findings as a predictive dactor for acute exacerbation of idiopathic pulmonary fibrosis., Yamaoka C, Horimasu Y, Iwamoto H, Ohshimo S, Fujitaka K, Hattori N, Hamada H, Kohno N., 第55回日本呼吸器学会学術講演会, 2015/04, Without Invitation, English, Tokyo, Japan
  96. 間質性肺炎急性増悪における体外式膜型人工肺(ECMO)の有用性, Ohshimo S, 日本医工学治療学会第31回学術大会, 2015/03/27, Without Invitation, Japanese, Hiroshima
  97. アナフィラキシーにおける凝固異常の検討, 山賀聡之, 大下慎一郎,木田佳子, 太田浩平,大谷直嗣,宇根一暢,岩崎泰昌,廣橋伸之,秀道広,谷川攻一, 第42回日本集中治療医学会学術集会, 2015/02, Without Invitation, Japanese, Tokyo, Japan, experimental
  98. 非HIV患者の重症ニューモシスチス肺炎に対する体外式膜型人工肺の有用性, 太田浩平, 大下慎一郎,木田佳子,山賀聡之,鈴木慶,稲川嵩紘,宇根一暢,岩崎泰昌,廣橋伸之,谷川攻一, 第42回日本集中治療医学会学術集会, 2015/02, Without Invitation, Japanese, Tokyo, Japan
  99. ECMOを成功させるためには:ECMO有効活用へ向けた当院の取り組み, 大下慎一郎, 第42回日本集中治療医学会学術集会, 2015/02, With Invitation, Japanese, Tokyo, Japan
  100. 間質性肺炎急性増悪におけるECMOの有用性, 木田佳子, 大下慎一郎,太田浩平,山賀聡史,鈴木慶、岩崎泰昌,廣橋伸之,谷川攻一, 第42回日本集中治療医学会学術集会, 2015/02, Without Invitation, Japanese, Tokyo, Japan
  101. 敗血症診断におけるPresepsinの有用性の検討, 鈴木 慶, 大下 慎一郎, 京 道人, 小山 和宏, 田邊 優子, 稲川 嵩紘, 太田 浩平, 岩崎 泰昌, 廣橋 伸之, 谷川 攻一, 第42回日本集中治療医学会学術集会, 2015/02, Without Invitation, Japanese, Tokyo, Japan
  102. Prognostic indicators for patients with acute respiratory failure treated with high-frequency oscillatory ventilation, Yuko Tanabe, Shinichiro Ohshimo, Yoshiko Kida, Kei Suzuki, Satoshi Yamaga, Kohei Ota, Kazunobu Une, Koichi Tanigawa, Annual Congress 44th Critical Care Congress, 2015/01, Without Invitation, English, Phoenix, Arizona, USA, published
  103. Correlation of intracellular histamine and clinical symptoms in anaphylactic patients, Satoshi Yamaga, Satoshi Morioke, Shinichiro Ohshimo, Kei Suzuki, Yasumasa Iwasaki, Nobuyuki Hirohashi, Michihiro Hide, Koichi Tanigawa, Annual Congress 44th Critical Care Congress, 2015/01, Without Invitation, English, Phoenix, Arizona, USA
  104. Usefulness of ECMO for acute exacerbation of interstitial pneumonia, Ohshimo S, The 31st Annual Meeting of the Japanese Society for Therapeutics Engineering, 2014/12/05, Without Invitation, Japanese, Hiroshima
  105. 広島県のヘリコプター救急医療体制 ドクターヘリ広域連携・消防防災ヘリとの連携, Otani T, 鈴木慶、木田佳子、山賀聡之、田邉優子、太田浩平、田村朋子、宇根一暢、貞森拓磨、大下慎一郎、津村龍、岩崎泰昌、廣橋伸之、板井純治、佐伯辰彦、多田昌弘、竹崎亨、楠真二、山野上敬夫、谷川攻一, 日本医工学治療学会第31回学術大会, 2014/12/05, Without Invitation, Japanese, Hiroshima
  106. 救急・集中治療領域における呼吸管理, Hirohashi N, Ohshimo S, Tanigawa K, 日本医工学治療学会第31回学術大会, 2014/12/05, With Invitation, Japanese
  107. 切除不能肺腺癌における予後予測マーカーとしての血清KL-6の有用性, 堀益 靖, 服部 登, 益田 武, 中島 拓, 岩本博志, 妹尾 直, 大下慎一郎, 石川暢久, 藤高一慶, 春田吉則, 村井 博, 宮田義浩, 岡田守人, 濱田泰伸, 河野修興, 第55回 日本肺癌学会学術集会, 2014/11, Without Invitation, Japanese, experimental
  108. Risk factors for severe anaphylaxis presenting prolonged hypotension, Satoshi Yamaga, Shinichiro Ohshimo, Satoshi Morioke, Tatsutoshi Shimatani, Michihito Kyo, Hiroshi Giga, Kazuhiro Koyama, Takahiro Inagawa, Kei Suzuki, Yoshiko Kida, Kohei Ota, Yuko Tanabe, Kazunobu Une, Tadatsugu Otani, Takuma Sadamori, Ryu Tsumura, Yasumasa Iwasaki, Nobuyuki Hirohashi, Michihiro Hide, Koichi Tanigawa, American Heart Association 2014, 2014/11, Without Invitation, English, Chicago, IL
  109. GAP Index as a predictor of acute exacerbation in idiopathic pulmonary fibrosis, Shinichiro Ohshimo, Yasushi Horimasu, Francesco, Bonella, Chihiro Yamaoka, Hiroshi Iwamoto, Kazunori Fujitaka, Yoshinori Haruta, Hiroshi Murai, Hironobu Hamada, Noboru Hattori, Nobuyuki Hirohashi, Koichi Tanigawa, Josune Guzman, Ulrich Costabel, Nobuoki Kohno, The 3rd combined WASOG and BAL Meeting, 2014/10, Without Invitation, English, experimental
  110. ドクターヘリ広域連携 消防・防災ヘリとの連携による効果, 大谷直嗣, 宇根一暢,太田浩平,山賀聡之,鈴木慶,大下慎一郎,津村龍,岩崎泰昌,廣橋伸之,山野上敬夫,谷川攻一, 第42回 日本救急医学会総会・学術集会, 2014/10, Without Invitation, Japanese, experimental
  111. 脂肪塞栓症候群によるARDSに対しV-V ECMOを導入し救命した一例, 島谷竜俊, 山賀聡之, 矢野佳子, 田邉優子, 太田浩平, 宇根一暢, 大下慎一郎, 岩崎泰昌, 廣橋伸之, 谷川攻一, 第42回 日本救急医学会総会・学術集会, 2014/10, Without Invitation, Japanese, experimental
  112. 広島大学病院高度救命救急センターにおける自殺企図者の実態について, 岩崎泰昌, 大下慎一郎, 大谷直嗣, 宇根一暢, 太田浩平, 山賀聡之, 木田佳子, 津村 龍, 廣橋伸之, 吉野敦雄, 谷川攻一, 第42回 日本救急医学会総会・学術集会, 2014/10, Without Invitation, Japanese, experimental
  113. Angiopoietin-2 Gene Polymorphism as Prognostic Factor in Caucasians with Idiopathic Pulmonary Fibrosis, Shinichiro Ohshimo, Yasushi Horimasu, Francesco Bonella, Hiroshi Iwamoto, Nobuhisa Ishikawa, Kazunori Fujitaka, Yoshinori Haruta, Hiroshi Murai, Noboru Hattori, Nobuyuki Hirohashi, Koichi Tanigawa, Josune Guzman, Ulrich Costabel, Nobuoki Kohno, European Respiratory Society International Congress 2014, 2014/09, Without Invitation, English, experimental
  114. Decreased circulatory receptor for advanced glycation end-products is associated with poorer survival in patients with idiopathic pulmonary fibrosis, Hiroshi Iwamoto, Yasushi Horimasu, Taku Nakashima, Tadashi Senoo, Shinichiro Ohshimo, Nobuhisa Ishikawa, Kazunori Fujitaka, Yoshinori Haruta, Hiroshi Murai, Noboru Hattori, Witold Mazur, Nobuoki Kohno, European Respiratory Society International Congress 2014, 2014/09, Without Invitation, English, experimental
  115. Annual changes in pulmonary function is an independent prognostic factor for the patients with chronic hypersensitivity pneumonia, Yasushi Horimasu, Nobuhisa Ishikawa, Taku Nakashima, Hiroshi Iwamoto, Tadashi Senoo, Shinichiro Ohshimo, Kazunori Fujitaka, Yoshinori Haruta, Hiroshi Murai, Noboru Hattori, Nobuoki Kohno, European Respiratory Society International Congress 2014, 2014/09, Without Invitation, English, experimental
  116. Potential value of KL-6 in various interstitial lung diseases, Shinichiro Ohshimo, European Respiratory Society International Congress 2014, 2014/09, With Invitation, English, published
  117. ARDS に対する換気様式の選択:高頻度振幅換気(HFOV)が有効なARDS患者をいかに選択するか, Ohshimo S, 第36回 日本呼吸療法医学会学術総会, 2014/07, Without Invitation, Japanese, experimental
  118. ECMOプロジェクト教育講演:VV-ECMO管理中に腸腰筋出血をきたした急性呼吸不全の一例, Ohshimo S, 第36回 日本呼吸療法医学会学術総会, 2014/07, With Invitation, Japanese, experimental
  119. Impact of Ethnic Difference and TERT Gene Polymorphisms in the Acute Exacerbation of Idiopathic Pulmonary Fibrosis, Shinichiro Ohshimo, Nobuhisa Ishikawa, Yasushi Horimasu, Kazunori Fujitaka, Yoshinori Haruta, Hiroshi Murai, Noboru Hattori, Francesco Bonella, Josune Guzman, Ulrich Costabel, Nobuoki Kohno, American Thoracic Society International Conference 2014. San Diego, California, USA, 2014/05, Without Invitation, English, experimental
  120. Serum CCL-18 may predict the short-term response to pirfenidone in idiopathic pulmonary fibrosis, Bonella Francesco, Costabel Ulrich, He Xuan, Ohshimo Shinichiro, Guzman Josune, Thomas E Wessendorf, ATS 2014 International Conference, 2014/05, Without Invitation, English, San Diego, California, experimental
  121. Annual decline in lung function can predict the prognosis of patients with chronic hypersensitivity pneumonia, Yasushi Horimasu, Nobuhisa Ishikawa, Taku Nakashima, Hiroshi Iwamoto, Tadashi Seno, Shinichiro Ohshimo, Kazunori Fujitaka, Yoshinori Haruta, Hiroshi Murai, Noboru Hattori, Nobuoki Kohno, ATS 2014 International Conference, 2014/05, Without Invitation, English, San Diego, California, experimental
  122. Gene expression profiles of idiopathic interstitial pneumonias: Molecular signatures of pulmonary fibrosis, Nobuhisa Ishikawa, Takeshi Masuda, Yasushi Horimasu, Noboru Hattori, Shinichiro Ohshimo, Nobuoki Kohno, ATS 2014 International Conference, 2014/05, Without Invitation, English, San Diego, California, experimental
  123. 人工呼吸器関連肺炎の 新しい判定基準:VAE, Ohshimo S, 国公立大学附属病院感染対策協議会中国四国ブロック別研修会, 2014/05, With Invitation, Japanese, published
  124. 広島県ドクターヘリの現状と取り組み, 大谷直嗣, 宇根一暢,津村龍,太田浩平,山賀聡之,鈴木 慶,田村朋子,貞森拓磨,大下慎一郎,岩崎泰昌,廣橋伸之,多田昌弘,佐伯辰彦,板井純治,竹崎 亨,楠 真二,山野上敬夫,谷川攻一, 第30回 日本救急医学会 中国四国地方会, 2014/05, Without Invitation, Japanese, experimental
  125. 急性呼吸不全におけるWearable-ECMO開発への取組み, Ohshimo S, 第54回 日本呼吸器学会学術講演会, 2014/04, Without Invitation, Japanese, experimental
  126. Impact of Ethnic Difference and TERT Gene Polymorphisms in the Acute Exacerbation of Idiopathic Pulmonary Fibrosis, Shinichiro Ohshimo, Nobuhisa Ishikawa, Yasushi Horimasu, Kazunori Fujitaka, Yoshinori Haruta, Hiroshi Murai, Noboru Hattori, Francesco Bonella, Josune Guzman, Ulrich Costabel, Nobuoki Kohno, 第54回 日本呼吸器学会学術講演会, 2014/04, Without Invitation, English, experimental
  127. 若手医師に役立つ実戦講座「呼吸管理のスタンダードから」:人工呼吸管理の羅針盤~ゴールデンスタンダードを求めて~ 新しいモニターシステム・画像・血清マーカー, Ohshimo S, 第54回 日本呼吸器学会学術講演会, 2014/04, With Invitation, Japanese, experimental
  128. 若者への留学の奨め-留学体験報告:ドイツ人とともに生活して見えてきたもの, Ohshimo S, 第54回 日本呼吸器学会学術講演会, 2014/04, With Invitation, Japanese, published
  129. Bubble like appearanceを呈する肺腺癌における気管支鏡検査の有用性, 濱井宏介, 石川暢久, 中島 拓, 岩本博志, 妹尾 直, 大下慎一郎, 藤高一慶, 春田吉則, 濱田泰伸, 村井 博, 服部 登, 河野修興, 第37回 日本呼吸器内視鏡学会学術集会, 2014/04, Without Invitation, Japanese, experimental
  130. Serum KL-6 Ausgangskonzentration korreliert mit der Langzeitprognose von lungentransplantierten Patienten, V. Bessa, S. Ohshimo, G. Weinreich , F. Bonella, U.Costabel, M. Kamler, H. Teschler, U. Sommerwerck, 55. Kongress der Deutschen Gesellschaft für Pathologie und Beatmungsmedizin, 2014/03/26, Without Invitation, German, Bremen, Germany
  131. Prevention of pneumothorax using veno-venous ECMO in acute respiratory distress syndrome with emphysematous/cystic changes in the lung, Tadatsugu Otani, Shinichiro Ohshimo, Kohei Ota, Yoshiko Kida, Takahiro Inagawa, Junji Itai, Satoshi Yamaga, Kazunobu Une, Yasumasa Iwasaki, Nobuyuki Hirohashi, Nobuoki Kohno, Koichi Tanigawa, 34 th International Symposium on Intensive Care and Emergency Medicine, 2014/03/18, Without Invitation, English
  132. ECMOを用いた重症呼吸不全治療における当院の取り組み, Ohshimo S, 第41回 日本集中治療医学会学術集会, 2014/02, With Invitation, Japanese, experimental
  133. 当院での敗血症性ショックに対するエンドトキシン吸着療法(PMX-DHP)の検討, 板井純治, 廣橋伸之,儀賀普嗣,稲川嵩紘,木田佳子,太田浩平,大谷直嗣,貞森拓磨,宇根一暢,大下慎一郎,津村龍,岩崎泰昌,谷川攻一, 第18回 エンドトキシン血症救命治療研究会, 2014/01, Without Invitation, Japanese, experimental
  134. 熱傷ショックにたこつぼ型心筋症を合併した高齢者熱傷の1例, 岩崎泰昌, 宇根一暢,太田浩平,大下慎一郎,稲川嵩紘,大谷直嗣,板井純治,木田佳子,廣橋伸之,谷川攻一, 第41回 日本集中治療医学会学術集会, 2014/01, Without Invitation, Japanese, experimental
  135. Serum KL-6 Levels Are Associated With Long-Term Prognosis in Lung Transplant Recipients, Vasilliki Bessa, Shinichiro Ohshimo, Gerhard Weinreich , Francesco Bonella, Ulrich Costabel, Markus Kamler, Helmut Teschler, Urte Sommerwerck, International Society for Heart & Lung Transplantation 34th Annual Meeting, 2014, Without Invitation, English
  136. Sedation and Muscle Relaxation in HFO, Shinichiro Ohshimo, High-frequency Oscillation (HFO) Experts Conference, 2014, With Invitation, English, published
  137. Serial change in serum KL-6 levels correlate with the pulmonary function variables in cystic fibrosis, Ohshimo S, 2010 ERS Annual Congress, 2010, Without Invitation, English
  138. KL-6, a Human MUC1 Mucin, as a Prognostic Factor for Diffuse Alveolar Hemorrhage Syndrome, Ohshimo S, 2010, Without Invitation, English
  139. びまん性肺胞出血症候群の;予後因子の検討, Ohshimo S, 第38回 日本救急医学会総会・学術集会, 2010, Without Invitation, Japanese
  140. HFOVによる呼吸管理が有用であった閉塞性気管支炎の一例, Ohshimo S, 第32回日本呼吸療法医学会学術総会, 2010, Without Invitation, Japanese
  141. Serum Levels of KL-6, a Biomarker for Interstitial Lung Diseases, in Caucasian Patients with Idiopathic Interstitial Pneumonias, Ohshimo S, 2010 ATS International Conference, 2010, Without Invitation, English
  142. KL-6 in whole lung lavage fluid of patients with pulmonary alveolar proteinosis, Ohshimo S, European Respiratory Society, 2009, Without Invitation, English
  143. 特発性間質性肺炎の日本・ヨーロッパ比較研究, Ohshimo S, 第50回日本呼吸器学会学術講演会, 2009, Without Invitation, Japanese
  144. Serum High-density Lipoprotein Cholesterol as a Prognostic Factor for Lung Cancer, Ohshimo S, The 19th International Symposium of Hiroshima Cancer Seminar, 2009, Without Invitation, English

Awards

  1. 2020/03/06, Reviewer of the year 2019, 日本集中治療医学会, Reviewer of the year 2019
  2. 2019/03/01, Reviewer of the year 2018, Reviewer of the year 2018
  3. 2018/07/11, Featured Research, Journal of Intensive Care, Comparison of extracorporeal membrane oxygenation outcome for influenza-associated acute respiratory failure in Japan between 2009 and 2016
  4. 2017/04/13, Researcher of Excellence, Pediatric Acute Respiratory Distress Syndrome Incidence and Epidemiology (PARDIE) Study
  5. 2014/10/08, Best Presentation Award, World Association for Sarcoidosis and Other Granulomatous Disorders, GAP index as a predictor of acute exacerbation in idiopathic pulmonary fibrosis

External Funds

Acceptance Results of Competitive Funds

  1. 2021, 2021
  2. 2021, 2021
  3. 2020, 2020
  4. 2020, 2020
  5. 2019, 2021
  6. 2019, 2021
  7. 2020, 2020
  8. 2019, 2021
  9. KAKENHI, 2013, 2015
  10. KAKENHI, 2013, 2016
  11. 文部科学省科学研究費助成金, 間質性肺炎急性増悪の人種差および好中球転写因子を用いた多角的病態解明と治療開発, 2016, 2018
  12. KAKENHI, 2016, 2018
  13. Japan Agency for Medical Research and Development, 2017, 2020
  14. 2017, 2017
  15. 2017, 2017
  16. 2017, 2017
  17. 2017, 2017
  18. 2017, 2020
  19. 2017, 2019

Social Activities

History as Committee Members

  1. Guideline Committee for Acute Respiratory Distress Syndrome, 2014/04, Japanese Society of Intensive Care Medicine, Japanese Society of Respiratory Care Medicine
  2. Guideline Committee for High-Frequency Oscillatory Ventilation, 2014, Japanese Society of Respiratory Care Medicine
  3. Task Force for Chronic Hypersensitivity Pneumonia, 2014, European Respiratory Society
  4. Crisis-management Committee, 2015, Japanese Society of Respiratory Care Medicine
  5. Councilor, 2009, Japanese Society of Internal Medicine
  6. 委員, 2015/04
  7. 厚生労働省難病医療費助成制度 難病指定医, 2015
  8. 日本医師会認定産業医, 2015

Organizing Academic Conferences, etc.

  1. 2019/04, 2019/08
  2. 2019/04, 2019/08

History as Peer Reviews of Academic Papers

  1. 2019, Tohoku Journal of Experimental Medicine, Others
  2. 2019, Therapeutic Advances in Respiratory Disease, Others
  3. 2017, Rheumatology, Others
  4. 2016, Rheumatology, Others
  5. 2019, Respirology, Others
  6. 2019, Respiratory Research, Others
  7. 2017, Respiratory Medicine, Others
  8. 2018, Respiratory Medicine, Others
  9. 2020, Respiratory Medicine, Others
  10. 2020, Respiratory Investigation, Others
  11. 2019, Respiratory Investigation, Others
  12. 2018, Respiratory Investigation, Others
  13. 2017, Respiratory Investigation, Others
  14. 2016, Respiratory Investigation, Others
  15. 2019, Respiratory Medicine, Others
  16. 2018, BMC Pulmonary Medicine, Others
  17. 2020, PLOS ONE, Others
  18. 2019, PLOS ONE, Others
  19. 2018, PLOS ONE, Others
  20. 2017, PLOS ONE, Others
  21. 2016, PLOS ONE, Others
  22. 2016, Pediatric Critical Care Medicine, Others
  23. 2017, Oncotarget, Others
  24. 2017, Military Medical Research, Others
  25. 2018, Medical Sciences, Others
  26. 2020, Liver International, Others
  27. 2017, Lancet Respiratory Medicine, Others
  28. 2019, Journal of Thoracic Disease, Others
  29. 2018, Journal of Thoracic Disease, Others
  30. 2018, Journal of Lung Health and Diseases, Others
  31. 2018, Journal of Infectiology, Others
  32. 2019, Journal of Clinical Medicine, Others
  33. 2018, Journal of Pain Research, Others
  34. 2020, Journal of Intensive Care, Others
  35. 2019, Journal of Intensive Care, Others
  36. 2018, Journal of Intensive Care, Others
  37. 2017, Journal of Intensive Care, Others
  38. 2016, Journal of Intensive Care, Others
  39. 2018, Expert Review of Respiratory Medicine, Others
  40. 2017, Dovepress, Others
  41. 2020, Journal of Critical Care, Others
  42. 2019, Journal of Critical Care, Others
  43. 2018, Journal of Critical Care
  44. 2017, Journal of Critical Care, Others
  45. 2019, J Clin Med, Others
  46. 2017, Journal of Cardiology, Others
  47. 2020, Journal of Artificial Organs, Others
  48. 2019, Journal of Artificial Organs, Others
  49. 2016, Journal of Artificial Organs, Others
  50. 2017, Journal of Artificial Organs, Others
  51. 2018, Journal of Artificial Organs, Others
  52. 2020, Journal of Anesthesia, Others
  53. 2019, Journal of Anesthesia, Others
  54. 2018, Journal of Anesthesia, Others
  55. 2017, Journal of Anesthesia, Others
  56. 2016, Journal of Anesthesia, Others
  57. 2019, Internal Medicine, Others
  58. 2018, Internal Medicine, Others
  59. 2017, Internal Medicine, Others
  60. 2018, International Journal of Molecular Sciences, Others
  61. 2020, Internal Medicine, Others
  62. 2020, International Journal of Medical Informatics, Others
  63. 2017, Infectious Disorders - Drug Targets, Others
  64. 2016, Infectious Disorders - Drug Targets, Others
  65. 2017, European Respiratory Review, Others
  66. 2019, Disease Markers, Others
  67. 2020, BMC Pulmonary Medicine, Others
  68. 2019, BMC Pulmonary Medicine, Others
  69. 2018, BMC Pulmonary Medicine, Others
  70. 2017, BMC Pulmonary Medicine, Others
  71. 2018, BioMed Research International, Others
  72. 2020, BMC Anesthesiology, Others
  73. 2020, American Thoracic Society, Others
  74. 2018, Acute Medicine & Surgery, Others
  75. 2019, Acute Medicine & Surgery, Others
  76. 2020, Acute Medicine & Surgery, Others
  77. 2020, Asian Cardiovascular and Thoracic Annals, Others
  78. 2014, Lab Invest, Others, Reviewer, 1
  79. 2014, BMC Pulm Med, Others, Reviewer, 2
  80. 2014, iConcept Press, Others, Reviewer, 1
  81. 2014, Respir Res, Others, Reviewer, 1
  82. 2014, Arch Med Res, Others, Reviewer, 1
  83. 2013, Case Rep Pulm, Others, Reviewer, 2
  84. 2015, Clinical Medicine Insights, Others, Reviewer, 5
  85. 2015, Pediat Int, Others, Reviewer, 1
  86. 2015, Inflammation, Others, Reviewer, 1
  87. 2014, Intern Med, Others, Reviewer, 1
  88. 2015, Dove Medical Press, Others, Reviewer, 1
  89. 2011, Respir Care, Others, Reviewer, 1
  90. 2013, Sarcoidosis vasculitis and diffuse lung diseases, Others, Reviewer, 1
  91. 2015, 集中治療会誌, Others, Reviewer, 1
  92. 2013, Eur Respir J, Others, Reviewer, 1
  93. 2015, Intern Med, Others, Reviewer, 1
  94. 2016, J Intensiv Care, Others, Reviewer, 2
  95. 2016, Respir Med, Others, Reviewer, 3
  96. 2016, Eur Respir Mon, Others, Reviewer, 1
  97. 2016, J Anesthesisa, Others, Reviewer, 2
  98. 2016, Rheumatology, Others, Reviewer, 1
  99. 2016, PLoS ONE, Others, Reviewer, 1
  100. 2016, J Artif Organ, Others, Reviewer, 2
  101. 2016, J intensive Care, Others, Reviewer, 5
  102. 2016, Respir Investig, Others, Reviewer, 1
  103. 2016, Infectious Disorders - Drug Targets, Others, Reviewer, 1
  104. 2016, BMC Pulm Med, Others, Reviewer, 2
  105. 2016, Pediat Crit Care Med, Others, Reviewer, 1
  106. 2016, Respir Med, Others, Reviewer, 3